Primary |
Osteoporosis |
43.2% |
Product Used For Unknown Indication |
27.9% |
Hypertension |
6.7% |
Pain |
4.2% |
Rheumatoid Arthritis |
1.7% |
Depression |
1.7% |
Hypothyroidism |
1.6% |
Back Pain |
1.4% |
Prophylaxis |
1.4% |
Senile Osteoporosis |
1.3% |
Supplementation Therapy |
1.2% |
Chronic Obstructive Pulmonary Disease |
1.1% |
Osteoporosis Postmenopausal |
1.0% |
Vitamin Supplementation |
1.0% |
Blood Pressure |
0.9% |
Gastrooesophageal Reflux Disease |
0.9% |
Diabetes Mellitus |
0.8% |
Medical Diet |
0.8% |
Asthma |
0.6% |
Blood Cholesterol |
0.6% |
|
Weight Decreased |
9.8% |
Pain In Extremity |
8.7% |
Vomiting |
7.5% |
Pneumonia |
6.3% |
Upper Limb Fracture |
6.3% |
Death |
5.9% |
Nausea |
5.9% |
Spinal Fracture |
5.5% |
Urinary Tract Infection |
4.7% |
Pain |
4.3% |
Somnolence |
3.9% |
Weight Increased |
3.9% |
Wrist Fracture |
3.9% |
Fall |
3.5% |
Myocardial Infarction |
3.5% |
Tremor |
3.5% |
Lung Disorder |
3.1% |
Malaise |
3.1% |
Sepsis |
3.1% |
Visual Impairment |
3.1% |
|
Secondary |
Product Used For Unknown Indication |
53.5% |
Osteoporosis |
28.1% |
Pain |
3.3% |
Senile Osteoporosis |
1.9% |
Hypertension |
1.8% |
Constipation |
1.2% |
Restless Legs Syndrome |
1.2% |
Depression |
1.0% |
Blood Pressure |
1.0% |
Rheumatoid Arthritis |
0.9% |
Gastrooesophageal Reflux Disease |
0.8% |
Osteoporosis Postmenopausal |
0.8% |
Arthritis |
0.7% |
Osteopenia |
0.7% |
Diarrhoea |
0.6% |
Rheumatic Disorder |
0.6% |
Rotator Cuff Syndrome |
0.6% |
Bone Disorder |
0.5% |
Vitamin D Decreased |
0.5% |
Atrial Fibrillation |
0.5% |
|
Vomiting |
14.6% |
Weight Decreased |
11.1% |
Wrist Fracture |
7.3% |
Upper Limb Fracture |
7.0% |
Pain |
5.5% |
Visual Acuity Reduced |
5.2% |
Weight Increased |
5.2% |
Somnolence |
4.7% |
Visual Impairment |
4.7% |
Pain In Extremity |
3.8% |
Pelvic Fracture |
3.8% |
Spinal Fracture |
3.8% |
Tremor |
3.8% |
Transient Ischaemic Attack |
3.2% |
Vitamin D Decreased |
3.2% |
Sinusitis |
2.9% |
Wrong Technique In Drug Usage Process |
2.9% |
Vertigo |
2.6% |
Medication Error |
2.3% |
Pneumonia |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
21.1% |
Rheumatoid Arthritis |
20.3% |
Osteoporosis |
12.8% |
Drug Use For Unknown Indication |
12.4% |
Hypertension |
6.1% |
Crohn's Disease |
3.6% |
Pain |
3.3% |
Blood Cholesterol Increased |
2.8% |
Vitamin Supplementation |
2.2% |
Mineral Supplementation |
1.8% |
Smoking Cessation Therapy |
1.8% |
Sleep Disorder |
1.6% |
Anaemia |
1.5% |
Gastrooesophageal Reflux Disease |
1.5% |
Asthma |
1.4% |
Diarrhoea |
1.4% |
Emphysema |
1.2% |
Hypothyroidism |
1.2% |
Chronic Obstructive Pulmonary Disease |
1.1% |
Osteoarthritis |
1.1% |
|
Injection Site Pain |
10.7% |
Weight Increased |
8.3% |
Rash |
7.1% |
Sleep Disorder |
7.1% |
Incorrect Dose Administered |
6.0% |
Pneumonia |
6.0% |
Vomiting |
6.0% |
Accidental Exposure |
4.8% |
Pain In Extremity |
4.8% |
Pyrexia |
4.8% |
Tinnitus |
4.8% |
Weight Decreased |
4.8% |
Hyponatraemia |
3.6% |
Pubis Fracture |
3.6% |
Staphylococcal Sepsis |
3.6% |
Tremor |
3.6% |
Vision Blurred |
3.6% |
Aortic Valve Stenosis |
2.4% |
Cardiac Failure |
2.4% |
Chest Pain |
2.4% |
|
Interacting |
Osteoporosis |
50.0% |
Hypertension |
25.0% |
Systemic Lupus Erythematosus |
25.0% |
|
Vision Blurred |
80.0% |
Malaise |
20.0% |
|